What is the appropriate acyclovir dose for treating varicella in healthy children and adults, and how should dosing be adjusted for severe disease, immunocompromised patients, or renal impairment?

Acyclovir Dosing for Chickenpox

For chickenpox treatment, use oral acyclovir 20 mg/kg (maximum 800 mg) four times daily for 5 days in children ≥2 years and over 40 kg, or 800 mg four times daily for 5 days in adults and children >40 kg, initiated within 24 hours of rash onset 1.

Dosing by Patient Population

Healthy Children (≥2 years)

• Oral acyclovir: 20 mg/kg per dose, 4 times daily (80 mg/kg/day total) for 5 days 1
• Maximum single dose: 800 mg
• Children >40 kg should receive the adult dose 1
• Critical timing: Must initiate within 24 hours of rash onset for efficacy 2

Adults and Adolescents (>40 kg)

• Oral acyclovir: 800 mg four times daily for 5 days 1
• Treatment is more strongly indicated in this age group due to higher risk of moderate-to-severe disease 2
• Adolescents and adults experience more severe varicella than young children 2

Immunocompromised Patients

• Intravenous acyclovir is required - oral therapy is insufficient 2
• IV dose: 10 mg/kg every 8 hours (or 500 mg/m² every 8 hours) 3
• Must be initiated within 24 hours of rash onset to reduce morbidity and mortality 2
• Duration: Typically 7-10 days, but may require prolonged courses in severely immunocompromised patients 4

High-Risk Otherwise Healthy Patients

Oral acyclovir should be considered for 2:

• Persons aged >12 years
• Chronic cutaneous disorders (e.g., eczema)
• Chronic pulmonary disorders
• Long-term salicylate therapy
• Short, intermittent, or aerosolized corticosteroid courses
• Secondary household contacts (some experts recommend)

Severe Disease or Complications

Switch to IV acyclovir for 2, 5:

• Varicella pneumonia
• CNS involvement (encephalitis)
• Disseminated disease
• Neonates (first 2 weeks of life)
• Preterm infants in NICU
• Severe disease in any patient

IV dosing for complications: 10 mg/kg every 8 hours for 7-10 days 3

Renal Impairment Adjustments

Dose modifications are essential - acyclovir is renally excreted and can cause nephrotoxicity 1:

For 800 mg every 4 hours regimen (standard chickenpox dose):

• CrCl >25 mL/min: 800 mg every 4 hours (5 times daily)
• CrCl 10-25 mL/min: 800 mg every 8 hours
• CrCl 0-10 mL/min: 800 mg every 12 hours 1

Hemodialysis patients:

• Administer an additional dose after each dialysis session 1
• Mean half-life during hemodialysis: ~5 hours with 60% plasma concentration decrease 1

Peritoneal dialysis:

• Loading dose: 400 mg
• Maintenance: 200 mg twice daily 6
• No supplemental dose needed after adjusting interval 1

Critical Safety Considerations

Nephrotoxicity Prevention

• Maintain adequate hydration - crystalluria and obstructive nephropathy can occur 1
• Risk increases after 4 days of IV therapy, affecting up to 20% of patients 7
• Monitor renal function closely, especially with:
  • Pre-existing renal impairment
  • Concurrent nephrotoxic agents
  • Elderly patients 1, 8

Neurotoxicity Risk

Watch for CNS symptoms in high-risk patients 6, 9, 8:

• Elderly patients
• Renal impairment (especially dialysis patients)
• Multiple comorbidities
• Polypharmacy

Neurotoxic symptoms (appear 2-4 days after initiation):

• Mental confusion, agitation
• Hallucinations, dysarthria
• Ataxia, tremors, involuntary movements
• Dizziness, blurred vision

Management: Discontinue immediately; symptoms are reversible with drug withdrawal and supportive care 6, 8

Special Populations

Pregnancy

• Category B drug - no teratogenic effects in animal studies 2
• Registry data (596 first-trimester exposures): birth defect rates approximate general population 2
• Not recommended for routine use in pregnant women with uncomplicated varicella 2
• IV acyclovir should be considered for serious complications (e.g., pneumonia) 2

Children <2 years

• IV acyclovir preferred over oral when treatment is indicated 5
• Oral dosing: 20 mg/kg four times daily if used 1

Important Clinical Caveats

When NOT to Use Acyclovir

• Routine treatment of healthy children <12 years is NOT recommended 2 - AAP determined insufficient clinical benefit to justify routine use
• Not for prophylaxis after varicella exposure in healthy individuals - vaccination is preferred 2
• Treatment initiated >24 hours after rash onset has uncertain efficacy 1

Post-Exposure Prophylaxis

• For immunocompromised patients: Use varicella-zoster immune globulin (VariZIG), not acyclovir 10, 2
• If VariZIG unavailable or >96 hours post-exposure: Some experts recommend acyclovir 20 mg/kg (max 800 mg) four times daily for 5-7 days 10

Monitoring During Treatment

• Renal function (especially days 4-7 of IV therapy)
• Mental status (particularly in elderly or renally impaired)
• Hydration status
• Urine output 1, 3

Augmented Renal Clearance (ARC)

Recent pediatric data suggests children with eGFR >250 mL/min/1.73 m² may require higher IV doses (15-20 mg/kg every 6 hours) to achieve therapeutic concentrations 11. Consider therapeutic drug monitoring in this population.